Stock Events

Conduit Pharmaceuticals 

$2.92
3
-$0.02-0.68% Friday 19:55

Statistics

Day High
3.07
Day Low
-
52W High
7.83
52W Low
2.25
Volume
26,863
Avg. Volume
20,572
Mkt Cap
215.58M
P/E Ratio
0
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap158.72B
Pfizer is a major player in the pharmaceutical industry, directly competing in several therapeutic areas that Conduit Pharmaceuticals targets.
Merck &
MRK
Mkt Cap329.42B
Merck operates globally in various pharmaceutical sectors, including those where Conduit Pharmaceuticals has significant investments.
Johnson & Johnson
JNJ
Mkt Cap360.79B
Johnson & Johnson offers a wide range of pharmaceutical products that compete across multiple segments with Conduit Pharmaceuticals.
Abbvie
ABBV
Mkt Cap283.86B
AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Conduit's interests.
AMGEN
AMGN
Mkt Cap166.38B
Amgen focuses on biotechnological medicines, including treatments in areas where Conduit Pharmaceuticals is actively researching.
Bristol-Myers Squibb
BMY
Mkt Cap91.1B
Bristol-Myers Squibb has a strong portfolio in areas like cancer and cardiovascular diseases, directly competing with Conduit's product lines.
Gilead Sciences
GILD
Mkt Cap82.18B
Gilead Sciences specializes in antiviral drugs and other areas that are key focus points for Conduit Pharmaceuticals.
Novartis
NVS
Mkt Cap223.59B
Novartis is a global healthcare company that produces drugs in direct competition with several of Conduit Pharmaceuticals' products.
Sanofi
SNY
Mkt Cap124.8B
Sanofi operates globally, offering drugs that compete in the same categories as Conduit Pharmaceuticals.
Lilly(Eli) &
LLY
Mkt Cap722.31B
Eli Lilly and Company is involved in pharmaceutical development in areas like diabetes and cancer, competing with Conduit Pharmaceuticals.

About

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Show more...
CEO
Employees
7
Country
US
ISIN
US20678X1063

Listings